PLOS is a non-profit organization on a mission to drive open science forward with measurable, meaningful change in research publishing, policy, and practice.

Building on a strong legacy of pioneering innovation, PLOS continues to be a catalyst, reimagining models to meet open science principles, removing barriers and promoting inclusion in knowledge creation and sharing, and publishing research outputs that enable everyone to learn from, reuse and build upon scientific knowledge.

We believe in a better future where science is open to all, for all.

Journals
More Content
PLOS BLOGS Speaking of Medicine and Health
Browse all PLOS Blogs
Browse all PLOS Blogs

This Week in PLOS Medicine: World Health Report; Cryptococcal meningitis; Multi-bi financing

Michael Morris General

Image Credit: Jenni C

Four new articles publish with the close of September, including our monthly editorial:

The PLOS Medicine Editors comment on the World Health Organization’s latest World Health Report, originally planned for publication in 2012, and the outcomes of the journal’s collaboration with WHO on the intended theme of “no health without research.”

David Boulware and colleagues assess the cost effectiveness of different treatment strategies in low- and middle-income countries for cryptococcal meningitis, one of the most common opportunistic infections of people with HIV.

Andrew Farlow reflects on new research by David Boulware and colleagues, highlighting current challenges in treating cryptoccocal meningitis and the lack of investment in research to treat this disease.

As part of a cluster of articles critically reflecting on the theme of “no health without research,” Devi Sridhar discusses a major challenge in the governance of research funding: multi-bi financing that allows the priorities of funding bodies to dictate what health issues and diseases are studied.

Remember you can comment on, annotate and rate any PLOS Medicine article and see the views, citations and other indications of impact of an article on that articles metrics tab.

Back to top